Injective price pares gains after ETF-driven spike
Injective price was down nearly 5% in 24 hours as the cryptocurrency experienced slight sell-off pressure following a sharp surge amid exchange-traded funds news.
- Injective price retreated slightly on July 29, falling about 5% as INJ touched lows of $13.88.
- The altcoin has surged on Monday amid news that Cboe had filed for the listing of the Canary Capital Staked Injective ETF.
- Institutional interest in INJ remains as the market eyes regulatory approvals for staked crypto ETFs, including for Ethereum and Solana.
The price of Injective ( INJ ) soared from lows of $14.48 to above $16.35.
However, after giving up some of the upside amid broader market struggles, INJ has extended the retreat. The coin touched lows of $13.88.
Market data on crypto.news showed Injective price hovered around $14.31, below the intraday low on July 28 and at risk of further losses as top cryptocurrencies face downside pressure.
Why did Injective surge?
Injective’s gains came as traders reacted to news that Cboe, the largest options exchange in the United States, had file d with the U.S. Securities and Exchange Commission for approval to list the Canary Capital’s Staked Injective exchange-traded fund .
The filing meant Canary’s staked Injective ETF joined other major staked crypto ETF flings – Ethereum ( ETH ) and Solana ( SOL ). It also points to the growing interest in Injective by institutional investors, which follows Canary’s registration of Delaware trust for the INJ ETF.
As the market reacted to the filing news, INJ price rose. However, like in many instances across the ecosystem, buy the rumor and sell-the-news scenario appears to have allowed for profit-taking.
INJ is not down by much, but price is hovering near a key level and fresh declines will push it support around $13.20.
Injective price 4-hour chart on TradingView
Despite the declines, analysts have pointed to Injective protocol’s price as signaling a bullish pennant on higher time frames.
Injective longs liquidated
Data from Coinglass shows a total of over $982,000 in Injective positions have been liquidated in the past 24 hours.
Of this, the vast majority are bullish bets at more than $895k. This liquidation hit for longs, with only $87k in shorts wiped out, also sees a decrease in open interest.
Coinglass data also indicates a decline of 10.4% in Injective OI, currently at around $167 million. Meanwhile, derivatives volume has fallen 16% to $413 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ripple Treasury Links AI With Digital Finance
UAE moves UAEPASS system for 12.5 million users to Avalanche blockchain
Anthropic’s AI economic impact model maps $30 trillion US economy, forecasts impact through 2030
Hedge funds have just rebuilt tech long positions, but Nasdaq's key support has begun to weaken
The Nasdaq 100 Index is approaching the lower boundary of its months-long consolidation range, with futures breaking below the uptrend line and the 100-day moving average, signaling technical weakness. Hedge funds had previously made substantial purchases of tech stocks, leading to concentrated positions that amplify downside risks. AI safety controversies and energy supply risks now serve as dual catalysts. If key support levels are lost while market panic remains subdued, volatility may be subject to a reassessment.
Crypto prices
More
